Brap2 functions as a cytoplasmic retention protein for p21 during monocyte differentiation

Molecular and Cellular Biology
Minoru AsadaS Mizutani

Abstract

The cell cycle inhibitor p21 plays an important role in monocytic cell differentiation, during which it translocates from the nucleus to cytoplasm. This process involves the negative regulation of the p21 nuclear localization signal (NLS). Here, we sought to determine the relationship between the cytoplasmic translocation of p21 and another molecule, Brap2, a cytoplasmic protein which binds the NLS of BRCA1 and was recently reported to inactivate KSR in the Ras-activating signal pathway under the name of IMP. We report that p21 and Brap2 directly interact, both in vitro and in vivo, in a manner requiring the NLS of p21 and the C-terminal portion of Brap2. When it is cotransfected with Brap2, p21 is expressed in the cytoplasm. Monocytic differentiation of the promyelomonocytic cell lines U937 and HL60 is associated with the upregulation of Brap2 expression concomitantly with the upregulation and cytoplasmic relocalization of p21. Our results underscore the role played by Brap2 in the process of cytoplasmic translocation of p21 during monocyte differentiation.

References

May 15, 1995·Genes & Development·C J Sherr, J M Roberts
Apr 1, 1997·Genes & Development·J LaBaerE Harlow
Oct 21, 2000·Genes & Development·V C Bromleigh, L P Freedman
Dec 2, 2000·Nature·R Scully, D M Livingston
Apr 17, 2001·The Journal of Biological Chemistry·M S Cyert
Nov 24, 2001·Trends in Cell Biology·S KuerstenI W Mattaj
Jan 5, 2002·The Journal of Biological Chemistry·Ying LiLaurence A Lasky
Jul 18, 2002·The Journal of Cell Biology·Hiroyuki TanakaMasaya Tohyama

❮ Previous
Next ❯

Citations

Mar 13, 2009·Functional & Integrative Genomics·Andrew ChenNicholas C Collins
Jan 20, 2009·Biotechnology Letters·Jing-Sen ChenRen-Ming Hu
May 17, 2005·Leukemia Research·Louis Ghanem, Richard Steinman
Mar 9, 2010·The Journal of Biological Chemistry·Janet C Koon, Terrance J Kubiseski
Jun 26, 2008·The Journal of Biological Chemistry·Jan CzyzykRichard A Flavell
Jun 15, 2011·Molecular Medicine·Yi-Chu LiaoSuh-Hang Hank Juo
Aug 24, 2006·Apoptosis : an International Journal on Programmed Cell Death·Ana Carolina Santos de SouzaCarmen Veríssima Ferreira
Nov 3, 2015·Journal of Molecular Biology·Mary ChristieBostjan Kobe
Sep 18, 2008·The Journal of General Virology·Yu-Hsiu LeeShih-Tung Liu
Nov 10, 2009·Biochemical and Biophysical Research Communications·Ji Young LeeJeongwon Sohn
May 3, 2011·Biochimica Et Biophysica Acta·Alex J Fulcher, David A Jans
May 7, 2009·FEMS Yeast Research·Christopher SnowdonGeorge van der Merwe
Mar 31, 2015·Scientific Reports·Shadma FatimaDavid A Jans
Dec 31, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Alex J FulcherDavid A Jans
Jul 29, 2020·G3 : Genes - Genomes - Genetics·Adilya RafikovaTerrance J Kubiseski
Apr 3, 2021·Frontiers in Plant Science·Katrina J LindenJudy Callis
Oct 10, 2018·G3 : Genes - Genomes - Genetics·Queenie HuTerrance J Kubiseski
Oct 5, 2011·Cold Spring Harbor Protocols·Yasufumi Kaneda

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.